Optimize Cognitive Measurement in Alzheimer’s Disease

Gather resources highlighting Cogstate's expert scientific and operational support for AD clinical trials.

Cogstate is at the forefront of Alzheimer’s disease research. We invite you to learn more about our leading data quality programs, rapid and well-validated digital cognitive assessments, and expert decentralized clinical trial solutions.

If you have any questions, please don’t hesitate to stop by our AAIC booth or send us an email at communications@cogstate.com.

Featured Resources

Alzheimer’s Disease Clinical Trial Support

Cogstate’s data quality programs and digital cognitive assessments are designed to help your research team enhance signal detection via improved measurement and trial design, and expert study conduct, enabling you to make important AD drug development decisions.

Decentralized Clinical Trial Solutions

As more clinical trials realize the potential of decentralization, Cogstate digital endpoints are enabling at-home, self-administered assessment and our remote rating services are enabling at-home clinician-administered assessment to drive both enhanced data quality as well as patient enrollment, engagement, and retention.

Computerized Tests for AD Screening

Cogstate computerized tests have been used extensively as rapid and reliable screening assessments in a range of clinical indications. The tests are well-validated assessment options for study teams looking for an efficient and effective way to identify cognitive impairment in all phases of AD clinical trials.

Rater Training and Central Monitoring Solutions

Cogstate supports all aspects of data quality programs—rater training and certification, subject eligibility review, eCOA deployment, central monitoring—with proven methodologies and leading technologies that drive endpoint reliability.

Cognitive Go/No-Go Decision-Making Criteria for AD Drug Development

A recent publication reviews how to use cognitive data for better Go/No-Go decision-making in AD clinical trials and how to apply robust decision-making criteria depending on the specific stage of development, mechanism of action, and design of the trial.

Scientific Presence at AAIC

For 20 years, Cogstate has proudly supported cognitive research with particular emphasis and experience in Alzheimer’s Disease. At this year’s AAIC event, our expertise and technology are part of 5 oral presentations and 18 posters.

Alzheimer’s Disease Clinical Trial Experience

90+
Studies across all phases
3.2K
Sites supported
57K
Subjects tested
7.7K
Raters and administrators trained
40
Countries
100
Languages

Solutions for Every Stage of Your Study Development

Cogstate’s clinical trial services, coupled with innovative operational approaches, advanced analytics, and scientific consulting, help research teams draw conclusions from study data faster and with more accuracy. Learn how we can support your study:

Scientific Consulting

Computerized Cognitive Assessment

Rater Training

Central Monitoring

Scale Management

Remote / At-home Testing

How can we help you optimize the measurement of brain health?

Please fill out the form to get in touch